CUV clinuvel pharmaceuticals limited

REPORT JUST DROPPED - Check this out!, page-2

  1. 181 Posts.
    lightbulb Created with Sketch. 89
    How about something meaningful instead of your endless, completely meaningless comparisons?And talking about EPP dominance at cuv is probably a joke. 500 patients corresponds to a penetration of at most 10%. If Wolgen were a good negotiator and not an egocentric, Clinuvel could actually have outstanding and influential market power in this area. He had more than a decade to do it. A missed opportunity that won't come back.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$9.79
Change
-0.040(0.41%)
Mkt cap ! $491.7M
Open High Low Value Volume
$9.89 $9.99 $9.66 $479.8K 48.86K

Buyers (Bids)

No. Vol. Price($)
4 14 $9.79
 

Sellers (Offers)

Price($) Vol. No.
$9.80 425 8
View Market Depth
Last trade - 12.55pm 16/06/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.